Effect of rokitamycin on human polymorphonuclear leukocyte chemotaxis. 1989

D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
Division of Infectious Diseases, Regional Hospital, Varese, Italy.

The effect of rokitamycin on human polymorphonuclear leukocyte (PMNL) chemotaxis was studied in vitro and in vivo. It was found that rokitamycin in vitro at a concentration of 20 micrograms/ml caused a diminution of PMNL migration, while at lower concentrations no significant effects on migration was observed. In in-vivo studies before and after the ingestion of rokitamycin by six healthy individuals, no change on PMNL chemotaxis was found.

UI MeSH Term Description Entries
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015644 Miocamycin A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections. Miokamycin,Ponsinomycin,9,3''-Di-O-Acetylmidecamycin,9,3''-Diacetylmidecamycin,Miocamycine,Myocamicin,PM-88908,9,3'' Di O Acetylmidecamycin,9,3'' Diacetylmidecamycin,PM 88908,PM88908

Related Publications

D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
March 1980, Journal of clinical & laboratory immunology,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
September 1979, Acta virologica,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
April 1994, The British journal of oral & maxillofacial surgery,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
January 1980, Advances in experimental medicine and biology,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
November 1983, American journal of veterinary research,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
August 1981, The British journal of dermatology,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
July 1982, Mycopathologia,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
March 1986, Cell biology and toxicology,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
January 1979, The American journal of physiology,
D Torre, and M Broggini, and S Rossi, and C Sampietro, and V Bottà
July 1980, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!